Spandidos Publications style
Aftimos PG, Wiedig M, Fontsa ML, Awada A, Ghanem G and Journe F: [Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles. Int J Oncol 66: 1, 2025.
APA
Aftimos, P.G., Wiedig, M., Fontsa, M.L., Awada, A., Ghanem, G., & Journe, F. (2025). [Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles. International Journal of Oncology, 66, 1. https://doi.org/10.3892/ijo.2024.5707
MLA
Aftimos, P. G., Wiedig, M., Fontsa, M. L., Awada, A., Ghanem, G., Journe, F."[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles". International Journal of Oncology 66.1 (2025): 1.
Chicago
Aftimos, P. G., Wiedig, M., Fontsa, M. L., Awada, A., Ghanem, G., Journe, F."[Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles". International Journal of Oncology 66, no. 1 (2025): 1. https://doi.org/10.3892/ijo.2024.5707
